|
市場調査レポート
商品コード
1261647
外科用ステープリングデバイスの世界市場規模、シェア、産業動向分析レポートタイプ別、製品タイプ別、最終用途別、地域別展望と予測、2022年~2028年Global Surgical Stapling Devices Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By End-use, By Regional Outlook and Forecast, 2022 - 2028 |
||||||
外科用ステープリングデバイスの世界市場規模、シェア、産業動向分析レポートタイプ別、製品タイプ別、最終用途別、地域別展望と予測、2022年~2028年 |
出版日: 2023年03月31日
発行: KBV Research
ページ情報: 英文 193 Pages
納期: 即納可能
|
外科用ステープリングデバイス市場規模は、2028年には79億米ドルに達し、予測期間中にCAGR9.4%の市場成長率で上昇すると予測されています。
多くの場合、外科医はこれらの技術を最適に使用するための科学的または臨床的基礎、あるいは特定の技術が持つ特定の利点から利益を得る方法を学ぶ必要があるかもしれません。そのため、たとえ機器がうまく機能しても、より良い結果を得るためには、外科医の専門知識、判断、逸話的証拠に頼ることが多いかもしれません。
外科手術の際によく使用され、ほぼ絶え間なく技術的な進化を遂げている機器に、外科用ステープラーがあります。これらの器具は適応性が高く実用的であるが、ステープルラインの漏れが術後の困難を招いた事例がよく報告されており、その多くは虚血とは無関係な問題が原因でした。
特に婦人科、胃腸、肥満症などの難易度の高い手術では、外科用ステープリング器具がますます重要になってきています。さらに、外科用ステープリング器具の使用により、新しい手術法の開発、既存の手術法の変更、臨床結果の向上が容易になります。侵襲性の低い治療法に対する需要が世界的に高まっていることが、外科用ステープリング装置市場の拡大を後押ししています。
COVID-19影響度分析
多くの病院が緊急時以外の外来診療を中止せざるを得なくなり、外科用ステープリング器具の市場に大きな影響を与えました。社会的排除、人口抑制、診療所へのアクセス制限などが、市場に大きな影響を与えました。しかし、重要なメーカーが市場シェアを拡大するために技術的に最先端のアイテムの導入に注力しているため、監禁規制が解除された後、市場は大きく成長すると予想されます。また、生産が軌道に乗り、外科手術が再開されて需要が高まっていることから、外科用ステープリングデバイス市場はパンデミック後に再び拡大し始めると考えられます。
市場成長要因
手術用ステープリングデバイスの技術向上について
外科用ステープルおよび関連ステープルの技術開発は、ヘルスケア従事者による外科用ステープル装置の受け入れに大きな影響を与えています。動力式外科用ステープラーのイントロダクションより、手術後の傷口を塞ぐのに必要な時間が短縮され、問題や出血を最小限に抑えることができるようになりました。臨床試験では、治癒のスピードと不快感の減少において、動力式外科用ステープラーがより優れた性能を発揮しました。したがって、外科用ステープリングデバイスが提供する技術的な利点が、市場の成長を促進すると予想されます。
慢性疾患の有病率の上昇
ここ数年、がんなどの慢性疾患が増加しているため、外来手術施設への来院者数も増加しています。さらに、患者が選択する腹腔鏡治療の増加により、外科用ステープラーの市場は予測期間を通じて成長すると予測されています。費用の減少、病院での入院期間の短縮、腹腔鏡手術の人気の高まりは、すべてこれらの要因に起因しています。したがって、慢性疾患の有病率が高く、腹腔鏡手術の人気が高まっていることから、外科用ステープリングデバイスの市場成長は急増すると思われます。
市場抑制要因
サージカルステープラーに共通する問題点
創傷部位のステープルラインの開き、密封が不十分なステープルの欠陥、ステープラーの欠陥や詰まり、ステープラーからステープルを発射できない、ステープルが間違った組織に不適切に配置された、特定の用途に不適切なサイズのステープルを使用しているなどは、ステープリング機器の使用に関する一般的な問題の一部です。このような問題が頻発すると、ホッチキスの傷ができ、治癒に要する時間が長くなり、患者さんに高い医療費とリハビリ費用がかかることになります。このような問題があるため、ステープリングデバイスの市場拡大が制限されると予想されます。
製品タイプの展望
製品タイプに基づき、外科用ステープリング装置市場は、パワードとマニュアルに区分されます。パワードセグメントは、2021年の外科用ステープリングデバイス市場で大きな収益シェアを獲得しました。これは、身体的な努力を必要とせずに創傷閉鎖ができる簡便さに起因しています。医療従事者は、さまざまなサイズの電動式外科用ステープリングデバイスを利用できるようになったため、選択肢が増えました。さらに、技術的進歩や製品の発売、企業が動力式ステープリング装置の開発に力を入れていることも、このセグメントの成長を後押しすると予想される要因の1つです。
タイプ別展望
タイプ別では、外科用ステープリングデバイス市場は、使い捨てと再利用可能なものに分けられます。2021年の外科用ステープリング器具市場では、再利用可能なセグメントが最も高い収益シェアを占めています。これは、再利用可能な外科用ステープリング器具は、滅菌後に複数の患者に使用することができるためです。この製品は低コストであるため、このカテゴリーは発展途上国でより大きなシェアを占めると予想されます。さらに、吸収性ステープラーと組み合わせた外科用ステープリング器具のイントロダクションは、予測期間中にセグメントの拡大を後押しすると予測されます。
エンドユースの展望
最終用途別では、外科用ステープリング装置市場は病院と外来手術センターに分類されます。病院セグメントは、2021年の外科用ステープリングデバイス市場で最大の収益シェアを示しました。これは、病院がロボット手術を含む臨床効率化モデルへの移行を指し示す大きな動向を見ているためです。低侵襲処置は、ロボット手術の恩恵を受けることができます。病院にはよく訓練されたスタッフとハイテク機器があるため、安全で成功する処置が保証されます。また、病院カテゴリーは、予測期間中、異なる方法に対する有利な償還条件により、優位性を維持すると予想されます。
地域別展望
地域別に、外科用ステープリング装置市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。北米地域は、2021年に外科用ステープリング装置市場で最も高い収益シェアを記録しました。これは、総手術件数の増加に伴う最先端技術や低侵襲手術の採用によるものです。さらに、世界で最も肥満が蔓延していること、多国籍企業の現地進出、低侵襲手術に対する政府の許可なども、大きな市場シェアの要因となっています。
市場参入企業がとる主な戦略は、製品の上市です。カーディナルマトリックスで提示された分析に基づくと、ジョンソン・エンド・ジョンソン(エチコン社)が外科用ステープリングデバイス市場で先行者となっています。Intuitive Surgical, Inc.、Medtronic PLC、Stryker Corporationなどの企業は、Surgical Stapling Devices市場における主要な革新者の一人です。
List of Figures
The Global Surgical Stapling Devices Market size is expected to reach $7.9 billion by 2028, rising at a market growth of 9.4% CAGR during the forecast period.
Surgical stapling devices apply surgical staples instead of sutures to heal skin wounds or keep tissue together. When operating time is an issue and aesthetic closure is not a top priority, surgical staples may help close injuries quickly. There are now three main categories of mechanical staplers for open and endoscopic surgery: linear, circular, and endoscopic surgical staplers.
Several novel surgical equipment and gadgets are now available because of technological advancements in various scientific fields. To enhance patient outcomes, surgeons can create novel surgical procedures due to the constant introduction of new instruments and the ongoing technological advances in already-existing technologies.
In many instances, surgeons may need to learn the scientific or clinical foundation for the best use of these technologies or how to benefit from any particular advantages a specific technology may have. So, even if the devices work well, surgeons may often depend on their expertise, judgment, or anecdotal evidence for better results.
Equipment that is often employed during surgical operations and is also undergoing a nearly continual state of technological evolution is the surgical stapler. While these tools are adaptable and practical, there have been well-reported instances of staple line leaks that resulted in postoperative difficulties, many of which were caused by problems unrelated to ischemia.
In operations, particularly challenging ones like gynecologic, gastrointestinal, & bariatric procedures, surgical stapling instruments are becoming more and more crucial. In addition, the use of surgical stapling devices facilitates the development of novel surgical techniques, the alteration of existing procedures, and the enhancement of clinical results. The increasing demand for less invasive treatments globally drives the expansion of the surgical stapling devices market.
COVID-19 Impact Analysis
The lockdown compelled many hospitals to stop their outpatient departments for situations other than emergencies, which had a significant impact on the market for surgical stapling devices. Social exclusion, population control, and restricted clinic access substantially influenced the market. However, the market is anticipated to grow significantly after the lockdown restrictions are lifted as significant manufacturers are concentrating on introducing technologically cutting-edge items to increase their market share. Also, with production getting back on track, and the resume in surgical procedures which is increasing the demand, the surgical stapling devices market will start to expand again after the pandemic.
Market Growth Factors
The technological betterment of surgical stapling devices
Technological developments in surgical staples and related staples have significantly impacted the acceptance of surgical stapling devices by healthcare practitioners. With the introduction of powered surgical staplers, the time needed to seal the wound after surgery has decreased, minimizing problems and blood loss. In clinical testing, the powered surgical stapler performed better in the speed of healing and decreased discomfort. Hence, it is anticipated that the technical benefits offered by surgical stapling devices will drive market growth.
Rising prevalence of chronic diseases
Due to the rise in chronic illnesses like cancer during the last several years, there has also been an increase in the number of visits to ambulatory surgical facilities. Moreover, it is predicted that the market for surgical staplers will grow throughout the projection years due to the rise in laparoscopic treatments chosen by patients. The decreasing cost, shorter hospital stays, and increasing popularity of laparoscopic operations are all due to these factors. Hence with the high prevalence of chronic cases and the rising popularity of laparoscopic operations, the market growth for surgical stapling devices will surge.
Market Restraining Factors
Common issues with surgical staplers
Opening of the staple line at a wound site, faulty staples that result in insufficient sealing, defective or jammed staplers, failing to shoot a staple from a stapler, staples that were improperly positioned on the wrong tissue spot using a staple that is the incorrect size for a particular application are some of the common issues associated with the usage of stapling devices. These frequent issues may result in surgical staple wounds, lengthening healing time and exposing the patient to higher medical and rehabilitation expenses. These issues with the stapling devices are expected to restrict their market expansion.
Product Type Outlook
Based on product type, the surgical stapling devices market is segmented into powered and manual. The powered segment acquired a significant revenue share in the surgical stapling devices market in 2021. This is due to their simplicity of wound closure without requiring physical effort. Medical professionals now have more options due to the availability of powered surgical stapling devices in various sizes. In addition, the escalating technical advancements, product launches, and firms' increased emphasis on developing powered stapling devices are among other factors which are anticipated to boost the segment growth.
Type Outlook
On the basis of type, the surgical stapling devices market is divided into disposable and reusable. The reusable segment held the highest revenue share in the surgical stapling devices market in 2021. This is because reusable surgical stapling instruments may be used on several patients after sterilizing. Due to the product's low cost, the category is expected to have a bigger share in developing countries. Furthermore, the introduction of surgical stapling devices combined with absorbable staplers is projected to boost the segment expansion in the projected period.
End Use Outlook
By end-use, the surgical stapling devices market is classified into hospitals and ambulatory surgical centers. The hospitals segment witnessed the largest revenue share in the surgical stapling devices market in 2021. This is because hospitals are seeing a significant trend that points to a move towards clinical efficiency models, including robotic surgery. Minimally invasive procedures benefit from robotic surgery. The hospitals have well-trained staff and high-tech devices, which ensures a safe and successful procedure. Also, the hospital category is anticipated to maintain its dominance due to favorable reimbursement conditions for different methods during the projection period.
Regional Outlook
Region-wise, the surgical stapling devices market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region registered the highest revenue share in the surgical stapling devices market in 2021. This is owing to the employment of cutting-edge technology and minimally invasive procedures with the rising number of total operations. In addition, the greatest obesity prevalence in the world, the local presence of multinational corporations, and the government's clearance for minimally invasive operations are other factors contributing to the large market share.
The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Johnson & Johnson (Ethicon, Inc.) is the forerunner in the Surgical Stapling Devices Market. Companies such as Intuitive Surgical, Inc., Medtronic PLC, and Stryker Corporation are some of the key innovators in Surgical Stapling Devices Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Medtronic PLC, BioPro, Inc., ConMed Corporation, Smith & Nephew PLC, Intuitive Surgical, Inc., Johnson & Johnson (Ethicon, Inc.), B. Braun Melsungen AG, Becton, Dickinson and Company and Meril Life Science Private Limited.
Recent Strategies Deployed in Surgical Stapling Devices Market
Product Launches and Expansions:
Jun-2022: Ethicon, part of Johnson & Johnson introduced the ECHELON 3000 Stapler intended to use in resection, transection, and creation of anastomoses. The ECHELON 3000 is available in 45mm and 60mm staplers. The new stapler is a single-patient-use, sterile, that can cut and staple both at the same time.
May-2022: Stryker introduced the EasyFuse Dynamic Compression System, which will be a part of Stryker's foot and ankle product portfolio. The new staple system is developed using a nickel-titanium alloy metal, known as nitinol. The EasyFuse Dynamic Compression System decreases complexity in surgeries. The newly launched product features, a wide staple bridge, an intuitively developed inserter, and sterile-packed instrumentation.
Jun-2021: Intuitive unveiled SureForm, a robotic-assisted surgical stapler SureForm. The surgical stapler comes with SmartFire technology, an integrated software. The SureForm allows the surgeon to simultaneously fire the stapler from the console itself, and perform the RAS procedure. Further, the launch of the robot-assisted stapler reflects the company's advancement towards simplification of the surgery procedure.
Mar-2021: Ethicon, part of Johnson & Johnson launched ECHELON+ Stapler equipped with Gripping Surface Technology (GST) Reloads. The new surgical stapler is developed to enhance staple line security, and lower complications. The stapler is equipped with a new motor with dynamic firing and a restructured ECHELON+Anvil.
Dec-2020: Medtronic launched Tri-Staple EEA Circular Stapler in India. The 3-row circular stapler is equipped with Medtronic's Tri-Staple technology and has multiple height staples. The new circular stapler is intended to use in colorectal procedures. Additionally, the device is also equipped with enhanced tactile and audible feedback that allows clinicians to make a better informed decisions in the operating room.
Feb-2020: Smith+Nephew introduced the CORI Surgical system. The new surgical systems are intended to enhance outcomes during knee arthroplasty, and also increase accuracy. Additionally, the CORI system is portable and easy to move from one theatre to the other.
Geographical Expansions:
Nov-2022: Becton, Dickinson, and Company (BD) expanded its global footprint by setting up a new manufacturing facility in Tijuana, Mexico. The new facility would primarily manufacture devices and technologies. The establishment of the new facility demonstrates BD's devotion to Mexico and its strong relationship with communities across Mexico. This new plant would further simplify BD's operations by integrating a distribution center, a manufacturing site, and the transportation of products to the end consumer all in one place.
Aug-2022: Stryker opened a new facility in Ireland. The new high-tech facility is a 156,000-square-foot facility, which would reinforce the company's market position in additive manufacturing.
Jun-2022: Smith+Nephew opened a new manufacturing and R&D facility in Hull, United Kingdom. The new facility is intended for its advanced wound management franchise. The establishment of the new facility reflects the company's commitment to the UK and to building a leading market position in advanced wound management.
Jun-2022: Stryker expanded its global footprint by setting up a new R&D facility in Haryana, India. The new 150,000-square-foot facility would advance innovation. Further, Stryker's Global Technology Centre (SGTC) reinforces the company's potential to develop and design new products and solutions.
Trials and Approvals:
Dec-2021: Intuitive received FDA approval for its SureForm 30. SureForm 30 is an 8 mm curved-tip stapler. The curved stapler is intended to use in thoracic, general, pediatric, urologic, and gynecologic surgeries.
Acquisitions and Mergers:
Sep-2022: B. Braun took over Clik-FIX Catheter Securement Devices from Starboard Medical. The acquisition includes a Clik-FIX Peripheral catheter securement device, Clik-FIX Universal catheter securement device, a Clik-FIX Neonatal PICC catheter securement device, and Clik-FIX PICC/Central catheter securement device. The combination of the Clik-FIX portfolio and B.Braun's competence and deep knowledge enables the acquirer to fulfill the growing needs of its clients and further strengthens its market position in the IV therapy market.
Nov-2020: Medtronic took over Medicrea, a France-based company primarily into developing, manufacturing, and marketing orthopedic implants intended for spinal surgery. This acquisition would reinforce Medtronic's position in personalized implants' AI-based prediction and planning capabilities.
Partnerships, Collaborations and Agreements:
May-2022: Intuitive teamed up with Creo Medical Group, a UK-based medical device company. The collaboration includes optimizing Creo's products to make them consistent with Intuitive's robotic technology.
Market Segments covered in the Report:
By Type
By Product Type
By End-use
By Geography
Companies Profiled
Unique Offerings from KBV Research